Europe Peripheral Intravenous Catheters Market

Europe Peripheral Intravenous Catheters Market Size (2022 to 2027)

The size of the Europe Peripheral Intravenous Catheters Market was around USD 1.25 billion in 2022. It is expected to grow at a CAGR of 5.6% to reach USD 1.64 billion by 2027. It captures 27% of the global market.

Y-O-Y growth in the incidence of chronic diseases, innovations in the new medical treatments, and healthcare expenditure in the European countries are majorly accelerating the peripheral intravenous catheters market in this region. The rising elder people population is accelerating the demand of the market. The rise in chronic diseases like cancer, stroke, diabetes, upgraded healthcare system, and favorable reimbursement structures mount the PIVC market growth in this region. A growing number of surgery cases, availability of upgraded catheters, and increasing awareness among the people population are expected to surge the PIVC market growth during the analysis period.

The cost associated with the peripheral intravenous catheters is so expensive, which is unaffordable by some small hospitals is restricting the market. Lack of trained and experienced professionals required to use these peripheral IV catheters is restraining the growth. Safety issues regarding the utilization of PIVC like different infections will obstruct the market.

The European Peripheral Intravenous Catheters Market has been segmented and sub-segmented into the following categories:

• By Product: Short PIVC (Ported Peripheral Intravenous Catheter and Non-ported Peripheral Intravenous Catheter) and Integrated/Closed PIVC   
• By Type: Integrated/Closed catheters and Peripheral insertion catheters     
• By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Home Use and Others   
• By Technology: Conventional Peripheral Intravenous Catheter and Safety Peripheral Intravenous Catheter
• By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe

Regional Analysis:

Europe was the second-largest in the global PIVC market. The escalating aging population, huge expenses on healthcare, and advanced technologies resulting in a high surgical procedure rate propel the PIVC market growth during the analysis period. The UK is governing the market with a surge in an unhealthy lifestyle; age-related factors add people prone to chronic diseases. Growth in parenteral drug approvals and a rise in biological drugs obtainable in injectable forms are fueling the growth. Germany followed after the UK is leading the market due to the growing large number of hospitals, which accounts for maximum revenue growth, thus growing skilled human resources. Mounting demand for integrated/closed peripheral intravenous catheters and growing assumption of safety small and short PIVC are accelerating the market. Rising consciousness about the minimum invasive surgeries integrated and utilizing upgraded materials like Teflon and polytetrafluoroethylene in the product is to foster the market growth during the analysis period. 

Key players in the Europe PVIC market profiled in this report are Smith Medical, Terumo Corporation, C. R. Bard, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Tangent Medical, and Vygon Group.